发明名称 CYSTEINVERMINDERTE MUTEINE VON INTERLEUKIN-2, IHRE HERSTELLUNG, ZUSAMMENSETZUNGEN, DIE DIESE MUTEINE ENTHALTEN SOWIE GENE, VEKTOREN UND ORGANISMEN, GEEIGNET ZUR VERWENDUNG BEI DER HERSTELLUNG DER GENANNTEN MUTEINE.
摘要 The invention provides muteins of biologically active proteins such as IFN- beta and IL-2 in which cysteine residues that are not essential to biological activity have been deleted or replaced with other amino acids to eliminate sites for intermolecular crosslinking or incorrect intramolecular disulfide bridge formation. These muteins may be made via bacterial expression of mutant genes that encode the muteins and have been synthesized from the genes for the parent proteins by oligonucleotide-directed mutagenesis.
申请公布号 DE3382528(D1) 申请公布日期 1992.04.16
申请号 DE19833382528 申请日期 1983.10.13
申请人 CETUS CORP., EMERYVILLE, CALIF., US 发明人 MARK, DAVID F., DANVILLE CALIFORNIA 94526, US;LIN, LEO S., FREMONT CALIFORNIA 94539, US;YU LU, SHI-DA, OAKLAND CALIFORNIA 94610, US
分类号 C07K14/555;A61K31/00;A61K35/74;A61K38/00;A61K38/21;A61P31/12;A61P35/00;A61P37/00;C07H;C07H21/04;C07K;C07K9/00;C07K14/00;C07K14/005;C07K14/195;C07K14/52;C07K14/525;C07K14/53;C07K14/54;C07K14/55;C07K14/56;C07K14/565;C07K19/00;C12N1/20;C12N1/21;C12N15/00;C12N15/09;C12N15/10;C12P;C12P19/34;C12P21/00;C12P21/02;C12R1/19 主分类号 C07K14/555
代理机构 代理人
主权项
地址